Aquestive Therapeutics Inc (AQST)
SG&A Expense Growth
59.13%
Fiscal year · Period ending:
AQST SG&A Expense Growth
Latest reported59.13%period ending
Latest reported59.13%period ending
AQST FY SG&A Growth (YoY) (0.00% → 59.13%)
Latest values, visible window
High-resolution chart · PNG
AQST sg&a expense growth history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expense Growth |
|---|---|
| 59.1251% | |
| 58.0472% | |
| -39.9573% | |
| -1.1145% | |
| -4.3244% | |
| -13.1329% | |
| -10.9626% | |
| 188.157% | |
| 20.5441% | |
| 0% |